A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients
Clinical trial NCT01745094 · COMPLETED
Trial details
- NCT number
- NCT01745094
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-07-23
- Enrollment
- 223
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.